LeonaBio Inc宣布,其针对Lasofoxifene的三期临床试验预计将在2026年第四季度完成患者招募工作。该试验的关键数据结果计划于2027年下半年对外公布。
LeonaBio Inc宣布,其针对Lasofoxifene的三期临床试验预计将在2026年第四季度完成患者招募工作。该试验的关键数据结果计划于2027年下半年对外公布。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.